Advances in bioinformatics and genomic data analysis have enabled the identification of cancer antigens that are generally overlooked during immune surveillance; these neoantigens have been shown to possess substantial therapeutic potential

... Read more

Excessive capital requirement and myriad of other complexities associated with the discovery of biologics have prompted drug developers to adopt in silico tools / techniques to expedite the discovery timelines

Roots Analysis ... Read more

Several big pharma companies are known to outsource more than half of their clinical-stage oligonucleotide manufacturing operations. Anticipating a sharp rise in demand, oligonucleotide manufacturers are increasingly consolidating their portfolios, building new capabilities and expanding their ... Read more

The applications of oligonucleotides are vast, even beyond the life science / pharma sector; however, owing to complexities associated with the synthesis and processing of these molecules, such operations are usually outsourced to capable CMOs

... Read more

The inherent advantages of peptide therapeutics, such as small size, low immunogenicity and better cellular uptake, has led to a rise in interest in such interventions. This is anticipated to create significant opportunities for CMOs offering peptide manufacturing services. However, in order to ... Read more

Given the growing demand for peptide drugs and the complexities associated with their development and production, relying on the superior technical expertise and experience of CMOs / CDMOs is presently a widely accepted business model

... Read more

The concept of microbiome-based therapeutics has generated significant enthusiasm within the medical science community, defining a new frontier in the field of medicine. Despite having captured the interest of several venture capital firms and big pharma players, no microbiome-based therapeutic ... Read more

Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030” report to its list of offerings ... Read more